Senti Biosciences Holdings, Inc. (SNTI)
Nasdaq: SNTI · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2021
Filings
280 filings since 2017 beside 88 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 15 days after the quarter ended. The proxy statement was last filed Apr 30, 2025.
Filings a yearinsider forms included
388858457465
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Oct 27, 2026.Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Sep 2, 2026.SEC letters: 4 in the last 36 months, the newest Mar 27, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Nov 9, 2026
Oct 27, 2026
8-K items 5.02, 8.01
Officer or director change; Other event · Current report
Oct 26, 2026
Oct 26, 2026
8-K items 1.01, 1.02, 2.01, 3.02, 9.01
Major agreement signed; Major agreement ended; Purchase or sale of a business completed; Shares sold without registration · Current report
Oct 21, 2026
Sep 4, 2026
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Sep 3, 2026
Sep 2, 2026
8-K items 1.01, 3.01
Major agreement signed; Listing warning from its exchange · Current report
Aug 27, 2026
Aug 20, 2026
8-K items 1.01, 2.03
Major agreement signed; New debt or obligation taken on · Current report
Aug 14, 2026
Jul 15, 2026
8-K items 1.01, 2.02, 5.01, 7.01, 8.01, 9.01
Major agreement signed; Results released; Change of control; Investor disclosure (Regulation FD); Other event · Current report
Jul 14, 2026
May 26, 2026
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
May 20, 2026
May 1, 2026
8-K items 1.01, 2.03, 3.02, 5.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Change of control · Current report
Apr 27, 2026
40 of 280 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.